USAntibiotics Reopens Facility and Returns Antibiotic Production to the United States from China

URLhttps://jacksonhealthcare.com/usantibiotics-reopen
SourceJackson Healthcare
Date Published08/30/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name USAntibiotics
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2021
Domestically, the work will be done:In-house
Country(ies) from which reshored:China
City reshored to:Bristol
State(s) reshored to:TN
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredantibiotics
What non-domestic negative factors made offshoring less attractive?Supply chain interruption risk/Natural disaster risk/Political instability
What domestic positive factors made reshoring more attractive?Impact on domestic economy, Under-utilized capacity, Biden
Find Reshoring Articles